prostaglandin, labour, pregnancy, obstetrics, delivery, normal labour, normal delivery, first stage of labour, induction of labour, pph, post partum haemorrhage, bleeding in pregnancy, abortion
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
prostaglandin, labour, pregnancy, obstetrics, delivery, normal labour, normal delivery, first stage of labour, induction of labour, pph, post partum haemorrhage, bleeding in pregnancy, abortion
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
Invited lecture by Dr Sujoy dasgupta in the Annual Conference of the "Academy of Clinical Embryologists" (ACE) held in October 2021 in "Hybrid mode" (Kolkata and Webinar)
Nuchal translucency
It is a sonographic pre natal screening scan to detect cardiovascular abnormality in a fetus.
NT can also detect altered extra cellular matrix composition and limited lymphatic drainage
Invited lecture by Dr Sujoy dasgupta in the Annual Conference of the "Academy of Clinical Embryologists" (ACE) held in October 2021 in "Hybrid mode" (Kolkata and Webinar)
Nuchal translucency
It is a sonographic pre natal screening scan to detect cardiovascular abnormality in a fetus.
NT can also detect altered extra cellular matrix composition and limited lymphatic drainage
Our aim is to reduce morbidity and mortality related to Non communicable diseases such as hypertension, diabetes, cardiovascular disease, stroke, Obesity, Cancer and lifestyle diseases among those least able to withstand the burden of the disease.
the slide is presentation of World Health Day. It has a very concise information touching various aspects of diabetes with the latest statistics. We hope this will be useful to everyone.
In this interactive lecture Dr. Vicky Guanzon joins me in discussing the updates on the Diagnosis and Treatment of Diabetes in Pregnancy. Delivered at the L'Fischer Hotel in Bacolod City on August 6, 2015.
Gestational diabetes Mellitus is defined as:
“Glucose intolerance of any severity with onset or first recognition during pregnancy”
This definition is applicable irrespective of whether the condition resolves after delivery or not.
It does not exclude the possibility that diabetes could have antedated pregnancy.
Similar to Recent Advances in the Diagnosis and Treatment of Gestational Diabetes (20)
A presentation on Medically Indicated Deliveries Before 39 weeks.
Includes updated information from ACOG.
Medically indicated late-preterm and early-term deliveries. Committee Opinion No. 560. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;121:908–10.
A preliminary proposal for an application to the Health Care Innovation Challenge sponsored by CMS. Focus of this proposal include gestational diabetes, maternal obesity, postpartum weight loss, and as well as patient engagement / health literacy
This lecture was originally given as a Prezi presentation at the Women & Infant's OB Conference for Dekalb Medical Center on March 7th, 2011. A full copy of the prezi can be found here: http://prezi.com/wrpz-mgq-nio/hypertensive-emergencies-in-obstetrics/
A brief presentation on some of the factors thought to be related to severe nausea and vomiting during pregnancy (Hyperemesis Gravidarum) with ways to treat this condition.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
3. WHAT IS DIABETES?
• Defect in energy regulation
• Defect in energy utilization
• Causes:
– Insulin deficiency
– Insulin resistance
• End result: Elevated blood sugar
• Impact of elevated blood sugar:
– Pregnancy complications
– Multi-organ dysfunction
– Excess mortality
4. 6 -7 percent of pregnancies
are complicated by
GDM
5. GDM is more common in certain ethnic
groups
These women also have an increased risk
of developing type 2 diabetes.
At risk groups:
Hispanic, African, Native American, Asian,
Pacific Islands.
6. 60% of Latina women with GDM will
develop type 2 DM.
This level of risk may actually
be manifest by 5 years after the GDM index
pregnancy.
7. Classification of Diabetes
Adapted from The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes
Care. 1997;20:1183-1197.
Type 1
b-cell destruction with lack
of insulin
Type 2
Insulin resistance and
relative insulin deficiency
Gestational Insulin resistance with b-
cell dysfunction
Other types
Genetic defects in b-cell
function,
Pancreatic disease,
Endocrinopathies,
Drug- or chemical- induced,
and other rare forms
13. TRADITIONAL RISK FACTORS:
Family history of diabetes
Previous unexplained stillbirth
Previous large infant
Obesity
Hypertension
Glycosuria
Maternal age older than 25
14. However,
More than half of all women
with GDM lack traditional risk factors
But,
it is NOT cost effective to screen women at
LOW risk for GDM.
15. Who is at LOW risk for GDM?
Low prevalence ethnic group
No known diabetes in first-degree relatives
Younger than 25 years
Normal weight before pregnancy
No history of abnormal glucose metabolism
No history of poor obstetric outcome
16. LOW risk women
represent only 10% of
pregnant population.
Identification of LOW risk women adds
complexity to screening process.
18. Diagnosis of Gestational Diabetes
Three Hour 100 gm glucose tolerance test (GTT)
Not necessary if GCT is >200mg/dl on screening
Two abnormal values required for the diagnosis of
gestational diabetes
Currently two diagnostic criteria acceptable
20. 1990
2000
1997-1998
No Data Less than 4% 4% to 6% Above 6%
Diabetes Trends Among
Adults in the U.S.
Source: CDC, Behavioral Risk Factor Surveillance System.
23. Normal Glucose Regulation in
Pregnancy
• The pregnant patient has a tendency to develop
HYPOGLYCEMIA between meals
– Related to fetal demand
• Placental steroids cause increased tissue insulin
resistance
– They are “DIABETOGENIC”
• Insulin production INCREASES in normal pregnancy
– By 30%
29. The Impact of Fetal Macrosomnia
• Increased hyperbilirubinemia
• Increased hypoglycemia
• Increased acidosis
• Increased birth trauma
• Macrosomic children are more likely to develop
glucose intolerance in adulthood
30. Congenital Anomalies and Diabetic Control
Risk for Congenital Anomalies at various levels of Hemoglobin
A1C
Critical periods - 3-6 weeks post conception
Importance of pre-conceptional metabolic care
2.5%
14.0%
23.0%
25.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
< 7.2
7.2 to 9.0
9.2 to 11.1
> 11.2
32. Pre-Pregnancy Management
• Preconceptional care
– PRECONCEPTION CARE BEGINS AT THE END OF A PREGNANCY
WITH GDM
– Tight glucose control (HbA1c)
– Assessment and treatment of associated medical problems
- Hypertension,
- Renal disease,
- Retinal disease
- Heart disease
– Folic acid
– Assessment of family, financial and personal resources to help
achieve a successful pregnancy
33. FIRST PERINATAL VISIT
or UPON HOSPITALIZATION
• Review routine prenatal lab tests
• Baseline 24 hour urinalysis for protein and creatinine
clearance
• Baseline retinal exam - for Type 1 Diabetics
• EKG - for Type 1 Diabetics
• Thyroid function tests - for Type 1 Diabetics
• Hemoglobin A1C
• Fetal echocardiogram for pregestational diabetics
34. Antepartum Gestational Diabetes Care
• Dietary advice
• Glucose monitoring (5 times per day)
• Insulin therapy if necessary
– Oral Hypoglycemic agents
• Frequent visits to monitor glucose control
• Ultrasound monitoring of fetal growth
• Mode of Delivery:
– Based on obstetric issues
• Timing of Delivery:
– Based on glucose control
35. What is an ADA diet?
•Avoidance of large meals with high
percentage of simple carbohydrates
•Three small meals with three snacks are
preferred
•Low glycemic index foods release calories
from the gut slowly and improve metabolic
control
36. What is an ADA diet?
• Caloric content:
– 35 calories/Kg Ideal body weight (or 15
calories/pound IBW)
– No less than 1800 calories and no more than 2800 calories
– “Eyeball Technique”
- Small patient 1800 calories
- Medium patient 2200 calories
- Large patient 2400 calorie
37. What is a “Low” Glycemic Index
• Glycemic Index (GI):
• Compares equal quantities of
carbohydrate in foods
• Is a measure of the effect on
blood glucose levels over a 2 hr
period
• Provides a measure of
carbohydrate quality.
• Expressed as a percentage
Time
GI = 30
GI = 100
BGLBGL
38. ‘Traditional’ starchy foods have a lower GI
• Barley
• Legumes/beans
• Multigrain ‘Specialty’ breads
• Mueslix
• Porridge oats
33
30’s
40’s
50’s
50’s
Foster-Powell K, Holt SHA, and Brand-Miller JC. International table of glycemic index and glycemic load values:2002. Am
J Clin Nutr. 2002; 76 (1): 5-56.
39. “Sugary” foods have a intermediate-low GI
• Soft drinks
• Flavoured milk (low fat)
• Yogurt (sweetened)
• Ice cream (low fat)
60’s
34
30-40
50’s
Foster-Powell K, Holt SHA, and Brand-Miller JC. International table of glycemic index and glycemic load values:2002. Am
J Clin Nutr. 2002; 76 (1): 5-56.
40. Modern starchy foods have a high GI
• Potatoes
• Cornflakes
• Rice crispies
• Wholegrain bread
• Crackers
• Rice (most types)
85
77
85
70
81
83
Foster-Powell K, Holt SHA, and Brand-Miller JC. International table of glycemic index and glycemic load values:2002. Am
J Clin Nutr. 2002; 76 (1): 5-56.
41. HOME GLUCOSE MONITORING
• Fasting and 2 hour post-
prandial
• Pre-meal values only if
sliding scale short acting
insulin coverage is used
• Early AM value if
hypoglycemia suspected
• Assure that glucose meter is
calibrated
43. Intensive Inpatient Management:
The APA Hybrid Protocol
• For poorly controlled diabetic patients admitted for
rapid control.
• Empiric insulin with the patient’s current standing
dose:
• Targets adequate glycemic control
– Fasting values: Less than 100 mg/dl
– 2 hour postparandial values: Less than 120 mg/dl
– Avoidance of hypoglycemia, ketonuria, and
hyperglycemia
44. Intensive Inpatient Management:
The APA Hybrid Protocol
• Begin 2200 to 2400 calorie ADA diet.
• Obtain fingerstick every 2 hours for 12-24
hours
• Administer HUMALOG INSULIN for sliding
scale
• Retake blood sugar at 2 hours after EACH
sliding dose noted below and repeat sliding
scale dose of insulin based on FSG.
• Adjust Insulin after 24 hours
45. Intensive Inpatient Management:
The APA Hybrid Protocol
Blood sugar value Administer the
following dosage of
humalog insulin
Recheck Blood sugar
< 140 Hold Humalog insulin 4-6 hours
140-1600 4 Units 2 hours
161-180 6 Units 2 hours
180-200 10 Units 2 hours
200-220 12 Units 2 hours
220-260 14 Units 2 hours
>260 16 Units 2 hours
46. 7/08 11/17/08 11/17/08 11/17/08 11/18/08
Column B
Column C
Patient CH – Before Hybrid Approach
200
300
Chart Title
Patient CH – After Hybrid Approach
48. THE APA INSULIN DRIP PROTOCOL
INTRAVENOUS FLUID MAINLINE: D5W @ 125 cc/hr
INSULIN DRIP:
Initially Check Fingerstick every hour
MIX 100 Units Regular insulin in 500 cc NS (0.2 U/cc)
TITRATE INFUSION AS FOLLOWS:
Fingerstick Value Drip Rate Units per hour
FS= <80 Turn off drip 0 U/hr
FS= 80-100 2.5 cc/hr 0.5 U/hr
FS=101-140 5.0 cc/hr 1.0 U/hr
FS= 141-180 7.5 cc/hr 1.5 U/hr
FS= 181-220 10 cc/hr* 2.0 U/hr
FS> 220 12.5 cc/hr* 2.5 U/hr
After Fingerstick has been between 80-140 x >2 hours, decrease
frequency of fingersticks to every 2 hours then every 4 hours.
49. HYPOGLYCEMIA DURING AN INSULIN DRIP
• For Glucose <60
– Turn off Insulin drip for 30 minutes
– Continue D5W (or D5LR) at 100 – 125 cc/hr
– Recheck Glucose after 30 minutes
– If blood glucose on recheck is still <60
- Give 25 ml of D50 IV (or 10-12 grams glucose)
– Recheck Blood Glucose every 30 minutes
- Restart insulin when glucose >101 mg/dl
50. INSULIN DRIP FOR THE INSULIN RESISTANT
PATIENT
• Method for poorly controlled, morbidly obese or noncompliant
patients with gestational diabetes
• 50% of total daily insulin dosage divided by 24 hours provides initial
rate for insulin drip.
• EXAMPLE:
– Ms. Jones current insulin regimen
- AM: 80units NPH 45 units Regular insulin
- PM: 60 units NPH, 55 units Regular insulin
– Total daily dosage= 240 units per day.
– ½ of 240 units = 120 units
– 120 units / 24 hours = 5 units per hour as initial
dosage.
51. Management - Postpartum
• Use pre pregnancy insulin levels when on diet and
monitor.
• If GDM monitor sugars only
• Immediate postpartum goal is fingerstick < 200
• GDM – Repeat GTT at 6 weeks postpartum
• GDM - long term risk of NIDDM
• Contraception